- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12.25 | Neola Medical AB: Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market | 98 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a U.S. patent protecting its disposable probes for the medical device Neola®. The advanced light and detector probes are used... ► Artikel lesen | |
| NEOLA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Neola Medical AB: Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements | 115 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted its first patent in China for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed... ► Artikel lesen | |
| 04.11.25 | Neola Medical AB Q3 Sales Increase | 4 | RTTNews | ||
| 04.11.25 | Neola Medical AB: Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola | 83 | GlobeNewswire (Europe) | Preliminary results from Neola Medical's ongoing clinical pilot study on preterm born babies indicate a robust safety profile of the medical device Neola®.
The preliminary findings indicate variations... ► Artikel lesen | |
| 04.11.25 | Neola Medical AB: Neola Medical Q3 Report 2025 - Progressing toward completion of Swedish clinical pilot study and strengthening leadership team | 56 | GlobeNewswire (Europe) | During the quarter Neola Medical strengthened the leadership team with appointment of a Clinical Director. In addition, the company's IP portfolio was reinforced in Europe with a newly granted patent... ► Artikel lesen | |
| 16.10.25 | Neola Medical AB: Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola | 126 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted patents in both the U.S. and China for a technical method that improve the accuracy of continuous lung monitoring with the company's medical device, Neola®.... ► Artikel lesen | |
| 25.09.25 | Neola Medical AB: Neola Medical strengthens leadership team with appointment of Clinical Director | 141 | GlobeNewswire (Europe) | Neola Medical AB (publ) is pleased to announce the appointment of Eva Bondesson as Clinical Director, effective October 1, 2025. As Neola Medical advances through the clinical phase, Eva Bondesson brings... ► Artikel lesen | |
| 10.09.25 | Neola Medical AB: Neola Medical granted European patent enabling lung monitoring beyond preterm born babies | 110 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a European patent for an invention aiming to enable lung monitoring in broader patient groups. This new patent complements the... ► Artikel lesen | |
| 25.08.25 | Neola Medical AB: Neola Medical Q2 Report 2025 - First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization | 131 | GlobeNewswire (Europe) | Neola Medical advanced its U.S. regulatory pathway in the second quarter of 2025, signing an agreement with Children's Regional Hospital at Cooper and securing IRB approval to enable the initiation... ► Artikel lesen | |
| 21.05.25 | Neola Medical AB: Neola Medical Q1 Report 2025 - Strengthened shareholder base with institutional investors ahead of clinical study start | 215 | GlobeNewswire (Europe) | The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximately... ► Artikel lesen | |
| 25.03.25 | Neola Medical AB: Neola Medical Signs Agreement with Södra Älvsborgs Sjukhus in Borås to Initiate Clinical Pilot Study on Preterm Born Babies | 142 | GlobeNewswire (Europe) | Neola Medical is pleased to announce the signing of a contract with Södra Älvsborgs Sjukhus in Borås, to conduct the company's first clinical pilot study on preterm born babies, with its continuous... ► Artikel lesen | |
| 05.03.25 | Neola Medical AB: Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring | 219 | GlobeNewswire (Europe) | Neola Medical AB has been granted a patent in China that strengthens the protection of the company's fundamental concept of measuring gases in body cavities using gas absorption spectroscopy for continuous... ► Artikel lesen | |
| 12.02.25 | Neola Medical AB: Neola Medical Q4 Report 2024 - Received approval for initiation of first clinical pilot study on preterm born babies | 217 | GlobeNewswire (Europe) | Neola Medical achieved key milestones in 2024, instrumental to its planned FDA application: securing the CB certificate and successfully completing the Human Factors Validation study. These accomplishments... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 29,340 | -16,65 % | Goldman Sachs senkt Daumen: Deutsche Medizintechniker Carl Zeiss Meditec und Fresenius Medical Care sacken ab | Goldman Sachs streicht die Kaufempfehlung für zwei Medizintechnik-Spezialisten und schlägt damit Anleger in die Flucht: um fünf Prozent rauscht der MDAX-Wert Carl Zeiss Meditec in der Früh in die Tiefe... ► Artikel lesen | |
| FRESENIUS | 48,470 | +1,74 % | Fresenius: Nach 5-Jahres-Hoch - Analysten weiter optimistisch | Der Trading-Tipp des Tages ist diesmal Fresenius. In diesem Jahr läuft es für die Aktie bisher sehr gut. Gestern erreichte das Papier sogar ein 5-Jahres-Hoch. Heute findet sich Fresenius zwar am DAX-Ende... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,110 | +1,10 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Der Konzernchef sowie der Finanzvorstand hätten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,490 | +2,35 % | DAX-Check LIVE: Aixtron, BASF, Bayer, Fresenius Medical Care, K+S, SAP, Schaeffler im Fokus | Nach sieben Rekordtagen in Folge haben am Mittwoch am deutschen Aktienmarkt die Verkäufer die Oberhand gewonnen. Der DAX schloss 0,5 Prozent tiefer bei 25.286 Punkten. Nach sieben Rekordtagen in Folge... ► Artikel lesen | |
| GERRESHEIMER | 27,300 | +9,20 % | Elmos, FMC, Gerresheimer, Hensoldt, Hypoport, Zalando: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,590 | +0,97 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 101,88 | +1,84 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,630 | +1,42 % | Alignment Healthcare stock price target raised to $28 by KeyBanc | ||
| PROGYNY | 24,990 | -1,81 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| ANTERIS TECHNOLOGIES GLOBAL | 6,570 | +8,42 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,770 | -0,55 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ADAPTHEALTH | 10,500 | -0,28 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| RXSIGHT | 9,860 | -0,90 % | Expert Outlook: RxSight Through The Eyes Of 5 Analysts | ||
| HEARTFLOW | 33,470 | -0,24 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| BETA BIONICS | 16,505 | +0,27 % | Beta Bionics, Inc.: Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 |
NEOLA MEDICAL AB gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEOLA MEDICAL AB finden Sie auf Wallstreet Online.